Tag: FDA

4

Rare Diseases: Regulatory Incentives for Development of Orphan Drugs – The United States & Europe

Many regulatory agencies across the world are offering incentives for the development of orphan drugs for rare diseases. These incentives include financial benefits, faster approvals, less stringent clinical data requirements, and many more. The countries that are offering the regulatory incentives for orphan drugs include the US, Europe, Japan, Australia, South Korea, Brazil, and most […]

Read More →
0

Want to Conduct Clinical Trials in the United States? Here’s what you need to know – Part 2

The United States is the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies requires considering many factors and areas. Starting with some salient points on Clinical trials in the United States. In the first part of this series of articles on clinical trials in […]

Read More →
2

Want to Conduct Clinical Trials in the United States? Here’s what you need to know – Part 1

The United States has consistently emerged as a leading site for clinical research. Half of the total clinical trials conducted worldwide are being conducted in the United States. Most of the research pharma companies prefer to perform their clinical trials in the United States due to the reasons such as well-established medical infrastructure, fast approval […]

Read More →